Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.
Poliovirus is an enteric virus that rarely invades the human central nervous system (CNS). To identify barriers limiting poliovirus spread from the periphery to CNS, we monitored trafficking of 10 marked viruses. After oral inoculation of susceptible mice, poliovirus was present in peripheral neurons, including vagus and sciatic nerves. To model viral trafficking in peripheral neurons, we intramuscularly injected mice with poliovirus, which follows a muscle-sciatic nerve-spinal cord-brain route. Only 20% of the poliovirus population successfully moved from muscle to brain, and three barriers limiting viral trafficking were identified. First, using light-sensitive viruses, we found limited viral replication in peripheral neurons. Second, retrograde axonal transport of poliovirus in peripheral neurons was inefficient; however, the efficiency was increased upon muscle damage, which also increased the transport efficiency of a non-viral neural tracer, wheat germ agglutinin. Third, using susceptible interferon (IFN) alpha/beta receptor knockout mice, we demonstrated that the IFN response limited viral movement from the periphery to the brain. Surprisingly, the retrograde axonal transport barrier was equivalent in strength to the IFN barrier. Illustrating the importance of barriers created by the IFN response and inefficient axonal transport, IFN alpha/beta receptor knockout mice with muscle damage permitted 80% of the viral population to access the brain, and succumbed to disease three times faster than mice with intact barriers. These results suggest that multiple separate barriers limit poliovirus trafficking from peripheral neurons to the CNS, possibly explaining the rare incidence of paralytic poliomyelitis. This study identifies inefficient axonal transport as a substantial barrier to poliovirus trafficking in peripheral neurons, which may limit CNS access for other viruses.
Lancaster
Karen Z
KZ
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Pfeiffer
Julie K
JK
D000818:Animals; D001370:Axonal Transport / Q000276:immunology*; D002490:Central Nervous System / Q000166:cytology / Q000276:immunology / Q000821:virology; D006367:HeLa Cells; D006801:Humans; D007273:Injections, Intramuscular; D007370:Interferon Type I / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D018482:Muscle, Skeletal / Q000293:injuries / Q000294:innervation / Q000821:virology; D009474:Neurons / Q000276:immunology / Q000821:virology; D011051:Poliomyelitis / Q000276:immunology* / Q000503:physiopathology / Q000821:virology; D017955:Poliovirus / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D053633:Receptor, Interferon alpha-beta / Q000235:genetics / Q000378:metabolism*; D011991:Receptors, Virus / Q000235:genetics / Q000378:metabolism; D012584:Sciatic Nerve / Q000166:cytology / Q000276:immunology / Q000821:virology; D014779:Virus Replication / Q000276:immunology
C508032:Ifnar1 protein, mouse; D007370:Interferon Type I; D011991:Receptors, Virus; C066100:poliovirus receptor; D053633:Receptor, Interferon alpha-beta